-
公开(公告)号：US20130156694A1
公开(公告)日：2013-06-20
申请号：US13716087
申请日：2012-12-15
申请人： Sergei B. Onikienko , Alex Nivorozhkin , Alexander V. Zemlyanoi , Mikhail Viktorovich Shorokhov , Vladimir Ivanovich Pereguda , Valery Aleksandrovich Chereshnev
发明人： Sergei B. Onikienko , Alex Nivorozhkin , Alexander V. Zemlyanoi , Mikhail Viktorovich Shorokhov , Vladimir Ivanovich Pereguda , Valery Aleksandrovich Chereshnev
IPC分类号： C07K14/435 , C07K16/46
CPC分类号： C07K14/47 , A61K38/1709 , C07K14/435 , C07K16/46 , C07K2319/00 , C07K2319/30 , C07K2319/50
摘要： The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70.
摘要翻译： 本发明涉及利用HSP70融合蛋白治疗由HSP70调节的病症或病症的新疗法。
-
2.发明申请NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS 审中-公开HSP70用于增加HSP70相关疾病的性能或治疗的新方法公开(公告)号：US20130090294A1
公开(公告)日：2013-04-11
申请号：US13536542
申请日：2012-06-28
IPC分类号： A61K38/17
CPC分类号： A61K38/17 , A61K38/1703 , A61K47/60
摘要： The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
摘要翻译： 本发明涉及利用外源性HSP70治疗通过施用外源HSP70而由HSP70调节的病症或病症的新疗法。
-
3.发明申请NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS 审中-公开HSP70用于增加HSP70相关疾病的性能或治疗的新方法公开(公告)号：US20140329764A1
公开(公告)日：2014-11-06
申请号：US14333483
申请日：2014-07-16
CPC分类号： A61K38/17 , A61K38/1703 , A61K47/60
摘要： The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
摘要翻译： 本发明涉及利用外源性HSP70治疗通过施用外源HSP70而由HSP70调节的病症或病症的新疗法。
-
公开(公告)号：US20130101573A1
公开(公告)日：2013-04-25
申请号：US13651416
申请日：2012-10-13
IPC分类号： A61K38/46
CPC分类号： A61K38/46 , A61K9/0075 , A61K9/1617 , A61K9/1647 , A61K38/1709 , A61K47/60
摘要： The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70. Furthermore, the present invention is directed to methods comprising the administration of stabilized exogenous HSP70 for use in the treatment of HSP70 related disorders or conditions, for example, for increased endurance or alleviating fatigue syndrome
摘要翻译： 本发明涉及利用稳定的外源性HSP70治疗由HSP70调节的病症或病症通过施用耐HSP70降解抗性制剂的新疗法。 此外，本发明涉及包含施用稳定的外源HSP70以用于治疗HSP70相关疾病或病症的方法，例如用于增加耐力或减轻疲劳综合征
-
-
-
搜索结果
4 条记录 (耗时 0.037 秒)